Delays in starting clopidogrel after stenting common, risky

By Megan Brooks

NEW YORK (Reuters Health) - Almost one in three patients fail to fill their prescription for clopidogrel within three days of hospital discharge after coronary stent implantation - and the consequences can be deadly, a new study confirms.

Hospital discharge "coincides with the period when patients are at greatest risk of stent thrombosis (early after implantation). So, perhaps not surprisingly, we found that any delay in obtaining a prescription was associated with a marked increase in the risk of death and myocardial infarction (MI) in the first 30 days after discharge," Dr. Nicolas Cruden, Consultant Cardiologist & Honorary Senior Lecturer, Edinburgh Heart Centre, United Kingdom, told Reuters Health by email.

To reduce the risk of stent thrombosis, guidelines recommend adjuvant clopidogrel, in combination with aspirin, for one month in patients receiving a bare metal stent (BMS) and six to 12 months in those getting a drug-eluting stent (DES).

Dr. Cruden and colleagues took a look back at 15,629 patients treated with coronary stents between 2004 and 2006; 3,599 received at least one DES, whereas 12,030 received a BMS alone.

The researchers report that 1,064 (30%) patients in the DES group and 3,758 (31%) in the BMS group failed to fill their prescription for clopidogrel within three days of hospital discharge. These "concerning" figures are consistent with previous work, the authors note in a report online May 28 in the Journal of the American Heart Association.

Patients who delayed filling their first prescription for clopidogrel by at least three days after hospital discharge were older, more likely to have had an ST-elevation MI, and had more comorbid illnesses than their peers who filled the prescription within three days of discharge, they say.

After regression analysis, a delay of more than three days was associated with a twofold or greater increased risk of death and recurrent MI, irrespective of stent type. The risk was greatest in the first 30 days after discharge. "Our findings complement and extend the results of earlier work," the authors say.

What can doctors do to encourage their patients to fill their medications promptly?

Dr. Cruden told Reuters Health, "Although we did not specifically address this in this study there are a number of areas we as physicians could do better: emphasize importance of taking clopidogrel, highlight risks of delay (quoting this study and others might help reinforce this); identify barriers to compliance." These barriers may include financial, behavioral or geographical such as living in remote/rural setting with limited access to pharmacy, he noted.

It might also help to provide patients with a supply of antiplatelet treatment to cover the highest risk period (first 30 days) on hospital discharge after PCI, "emphasizing need to fill prescription thereafter," Dr. Cruden said. Telephone follow-up to remind patients in days/weeks after discharge is another strategy. "However, further work is needed to assess the impact of these interventions."

The study was supported by the Victoria Heart Institute Foundation. The authors have no disclosures.

SOURCE: http://bit.ly/1wnhh6x

J Am Heart Assoc 2014.

(c) Copyright Thomson Reuters 2014. Click For Restrictions - http://about.reuters.com/fulllegal.asp